Summary
A randomised multicentre double-blind study was conducted to compare the efficacy and safety of roxatidine acetate 75mg twice daily and ranitidine 150mg twice daily in 295 patients with endoscopically confirmed gastric ulcers. Substantial reductions in ulcer diameters and healing rates of 85.6 and 88.2% for roxatidine acetate and ranitidine, respectively, were obtained after 8 weeks of treatment. There was no difference in healing rates between smokers and non-smokers in either group. The relief of day and night-time epigastric pain was comparable for both treatment groups, as was antacid tablet consumption, with the majority of patients pain-free at the end of the study. The incidence of side effects was low, with 3 patients treated with roxatidine acetate, compared with 4 ranitidine-treated patients, reporting adverse reactions. There were no clinically significant changes in laboratory values.
The present study suggests that 8 weeks of treatment with roxatidine acetate 75mg twice a day produces effective and safe acute management of gastric ulcers which is comparable to that seen with ranitidine.
Similar content being viewed by others
References
Boyd EJS, Wilson JA. Smoking impairs therapeutic gastric inhibition. Lancet 1: 95–97, 1983
Brogden RN, Heel RC, Speight TM, Avery GS. Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15: 93–131, 1978
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24: 267–303, 1982
Gugler R, Rohner H-G, Kratochvil P, Brandstätter G, Schmitz H. Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut 23: 866–871, 1982
Hentschel E, Schütze K. A comparison of roxatidine acetate 150mg once daily and 75mg twice daily in duodenal ulcer healing. Drugs 35 (Suppl. 3): 96–101, 1988
Hüttemann W. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing. Drugs: 35 (Suppl. 3): 90–95, 1988
Ireland A, Colin-Jones DG, Gear P, Golding PL, Ramage JK, et al. Ranitidine 150mg twice daily vs300mg nightly in treatment of duodenal ulcers. Lancet 11: 274–275, 1984
Lane MR, Lee SP. Gastric ulcers: investigations and treatment. Comprehensive Therapy 10: 24–31, 1984
Massarrat S, Eisenmann A. Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. Gut 22: 97–102, 1981
Misiewicz JJ. Medical management of peptic ulcer. Postgraduate Medical Journal 60: 751–759, 1984
Piper DW. Peptic Ulcer. ADIS Health Science Press, Australia, 1982
Whitfield PF, Hobsley M. Smoking and gastric hypersecretion in duodenal ulcer patients. Gut 20: A919, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Judmaier, G. A Comparison of Roxatidine Acetate and Ranitidine in Gastric Ulcer Healing. Drugs 35 (Suppl 3), 120–126 (1988). https://doi.org/10.2165/00003495-198800353-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800353-00021